Leading Companies Fortifying Their Presence in the Implantable Collamer Lens Market

The implantable collamer lens (ICL) market is poised for significant expansion in the coming years, driven by advancements in vision correction technologies and growing patient demand for less invasive eye care solutions. This sector is evolving rapidly as more people seek alternatives to traditional corrective eyewear, offering promising opportunities for manufacturers and healthcare providers alike.

Projected Market Growth for Implantable Collamer Lenses by 2030
The implantable collamer lens market is on track to reach $28.74 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.7%. This upward trend is largely fueled by the increasing preference for premium vision correction options, a heightened emphasis on minimally invasive ophthalmic surgeries, and a rise in elective eye care procedures. Additionally, investments in cutting-edge ophthalmology technologies and greater patient awareness about the benefits of implantable collamer lenses are playing key roles in expanding the market. Notable trends expected to influence this growth include the wider adoption of EVO implantable collamer lenses, increased use of laser-assisted implantation techniques, growing demand for reversible vision correction solutions, the development of customized lens designs, and a stronger focus on ensuring long-term visual stability.

Download a free sample of the implantable collamer lens market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20840&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Mar_PR

Leading Companies Driving the Implantable Collamer Lens Market
Several prominent players dominate the implantable collamer lens industry. Key companies include STAAR Surgical Company, Care Group Sight Solutions (IPCL), Ophtec (Artisan Phakic IOLs), Rayner Surgical, Hoya Surgical Optics, Alcon Inc., Johnson & Johnson Vision/Abbott Medical Optics, Bausch + Lomb, Carl Zeiss Meditec AG, Nidek Co. Ltd., Lenstec Inc., SIFI S.p.A., Optimedical, Eyeonics (now part of Santen), Physiol LLC, Microlens Tech Co. Ltd., HumanOptics AG, Ocular Instruments Inc., Aaren Scientific LLC, and Visiogen Inc.
A notable development occurred in May 2025 when Alcon, a Swiss eye care company, acquired STAAR Surgical for around $1.5 billion. This acquisition aims to strengthen Alcon's surgical vision correction portfolio, complementing its laser vision correction offerings and catering to patients with moderate to high myopia. STAAR Surgical, based in the U.S., is well-known for its implantable collamer lens products.

Emerging Innovations Transforming the Implantable Collamer Lens Market
Innovative technologies are at the forefront of growth in this market, with a focus on biocompatible, minimally invasive lenses that can correct a broad range of refractive errors without removing corneal tissue. These advancements improve patient outcomes by offering safe and reversible vision correction, reducing dependence on glasses and contact lenses, and speeding up recovery times.
For example, in March 2024, STAAR Surgical announced that over three million EVO ICL lenses have been implanted worldwide. The EVO ICL offers correction for myopia, with or without astigmatism, as well as presbyopia, through a quick 20 to 30-minute procedure that places the lens between the iris and the natural crystalline lens. This biocompatible and removable lens is regarded as a next-generation alternative to traditional eyewear, helping millions achieve improved vision effectively and comfortably.

View the full implantable collamer lens market report:
https://www.thebusinessresearchcompany.com/report/implantable-collamer-lens-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Mar_PR

Segments Fueling Growth in the Implantable Collamer Lens Market
The implantable collamer lens market is segmented into various categories to better understand its growth drivers:
1) By Type: Visian Implantable Collamer Lens (ICL), EVO Implantable Collamer Lens (ICL)
2) By Technology Adoption: Laser-Assisted Techniques, Traditional Techniques
3) By Application: Myopia, Hyperopia, Astigmatism
4) By End User: Ophthalmic Clinics, Hospitals, Ambulatory Surgical Centers, Other End Users

Further breakdowns include:
- Visian Implantable Collamer Lens (ICL) subcategories covering correction for myopia, hyperopia, astigmatism, and presbyopia.
- EVO Implantable Collamer Lens (ICL) subcategories also addressing myopia, hyperopia, astigmatism, and presbyopia.

These segments reflect the diverse range of applications and technological preferences shaping the implantable collamer lens market's future.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.